This collaboration will transform the way clinical research is
conducted by incorporating HealthTalk A.I.'s patient engagement
technology into Ambitna's best-in-class trial framework.
RESTON,
Va., May 8, 2024 /PRNewswire-PRWeb/ --
HealthTalk A.I., a leading patient engagement company, today
announced its partnership with Ambitna, a global technology company
dedicated to advancing healthcare through its innovative clinical
trials infrastructure. This collaboration marks HealthTalk A.I.'s
entrance into the clinical trials space, furthering its mission to
streamline patient-provider connections and improve healthcare
outcomes.
We are thrilled to partner with HealthTalk
A.I. By integrating their AI patient engagement platform with
Ambitna's robust clinical trials infrastructure, we can empower
patients to play a more active role in their healthcare journey,
leading to less dropouts and better outcomes for all.
By leveraging cutting-edge technology and a focus on health
equity, Ambitna aims to reduce health disparities and improve
access to clinical research for all. Remy Szykier, President of
Ambitna, expressed excitement about the partnership, stating, "We
are thrilled to partner with HealthTalk A.I. By integrating their
AI patient engagement platform with Ambitna's robust clinical
trials infrastructure, we can empower patients to play a more
active role in their healthcare journey, leading to less dropouts
and better outcomes for all."
Jerrod Ullah, CEO and Founder of
HealthTalk A.I., shared her enthusiasm for the partnership, saying,
"At HealthTalk A.I., we believe that patient engagement is
paramount in driving successful clinical trials. Our collaboration
with Ambitna allows us to combine our expertise in AI patient
engagement with Ambitna's innovative clinical trials offering,
ultimately revolutionizing the way clinical research is
conducted."
HealthTalk A.I.'s AI patient engagement platform alleviates many
of the administrative burdens associated with clinical trial
adherence by automating actions to recruit, monitor, and support
patients throughout their paths to health and wellness. With
Ambitna's visionary approach to healthcare and HealthTalk A.I.'s
innovative technology, this partnership is poised to revolutionize
the clinical trials landscape.
About Ambitna
Ambitna is a U.S. headquartered, global technology company
committed to advancing healthcare through a robust clinical trials
infrastructure. Their ambitious approach to accelerating innovation
begins with clinical research, aiming to reach people where they
are and improve health equity in clinical trials, thereby reducing
health disparities. At Ambitna, they're not just reimagining
healthcare; they're revolutionizing it. To learn more, visit
Ambitna.com.
About HealthTalk A.I.
HealthTalk A.I. was formed to change the way healthcare
organizations and patients connect. Their AI-assisted patient
engagement platform drives access by overcoming traditional
communication barriers and directing patients to the right resource
at the right time. Providers have the ability to engage 100% of
their patient population and close the loop with clinical
encounters and customer recovery actions. To learn more, visit
HealthTalkAI.com.
Media Contact
Jeremy Mitchell, HealthTalk A.I.,
1 404-819-4589, jeremy@healthtalkai.com,
https://www.healthtalkai.com
Twitter
View original content to download
multimedia:https://www.prweb.com/releases/healthtalk-ai-partners-with-ambitna-to-revolutionize-clinical-trials-302138806.html
SOURCE HealthTalk A.I.